Advertisement

Topics

EU, US & Japan Tackle Difficulties With Randomized Trials Involving Multi-Drug Resistant Bacteria

07:37 EDT 20 Jun 2017 | SCRIP

The European Medicines Agency has given the Pink Sheet more detail on its recent agreement with its counterparts in the...

      

Related Stories

 

Original Article: EU, US & Japan Tackle Difficulties With Randomized Trials Involving Multi-Drug Resistant Bacteria

NEXT ARTICLE

More From BioPortfolio on "EU, US & Japan Tackle Difficulties With Randomized Trials Involving Multi-Drug Resistant Bacteria"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...